Opinion: Outing Melanoma
24 February 2016
Melanoma strikes Susie Maroney. An Australian golden girl who made the seas her element has the misfortune to encounter an Australian fact of life and one of our best-kept national secrets. We have the world’s highest rates of melanoma, 12 times the global average. The tragedy is that melanoma is 95% preventable, but we in Australia have a passionate love affair with the sun and just don’t like to talk about the downside. At 41, Susie is young, a mother with three children who needs to have many years ahead of her. She has overcome many obstacles in her life thus far and we hope melanoma will simply be another one.
Treatment for melanoma, the most dangerous form of skin cancer, has made marathon progress in the past five years, much of it led by Australian clinicians and researchers at Melanoma Institute Australia. Previously, the only treatment for melanoma was surgery. Today, immunotherapy, targeted therapy and radiotherapy have claimed their places as additional disciplines. A tripling of life expectancy has been achieved for people with advanced disease. While the research effort turbocharges, to prevent melanoma we have to go back to the basics.
If there is one message we would like to reach the public, it is that melanoma is the most common cancer amongst 15-39 year olds. And in 20-34 year olds it kills more young Australians than any other cancer. No one is bullet-proof. Melanoma can manifest anywhere: it’s not always a changing mole on your back, such as Susie found. It can appear on the soles of your feet, the palms of your hands, under the hair on your scalp, even under a toenail or a tattoo. And you won’t know it’s there.
An Omnipoll we recently commissioned revealed that 39 percent of Australians aged 18–34 have never had a skin check and 78% have not had one in the past year. If you’re over 20 in Australia today, you should have an initial skin check by a GP or at a skin check clinic. They can then advise, based on your personal risk factors, how often your skin needs to be checked from head to toe in the future. If melanoma is caught early, it is now very treatable.
At 17, Susie was the youngest swimmer to cross the English Channel both ways and went on to capture many more records. She has declared that during her many, many kilometres in the ocean, she did not wear sunscreen. Regular use of sunscreen and covering up with UV-protective fabrics goes a long way. On land, broad-brimmed hats and wrap-around sunglasses also help as does taking shelter in shade.
Let’s bring melanoma out of the shadows.
Chief Executive Officer, Melanoma Institute Australia
Professor Richard Scolyer will be sharing his expertise on melanoma pathology at the upcoming Australasian Melanoma Conference. Here he discusses what he'll be presenting on.
Researchers at MIA have established a High Risk Clinic to monitor people at very high risk of developing melanoma.
A generous donation has enabled a medical oncologist from Portugal to learn from the best in the world at MIA.
MIA is hosting a conference to bring together greats minds in melanoma research that will make a difference to the lives of melanoma patients
Meet Michelle, our Translational Research Officer whose role is to connect the clinics to the lab by ensuring patient blood and tissue samples are documented and carefully stored in our BioSpecimen Bank.
Dr James Wilmott says his Wildfire Award will help expand research into treatment options for people with mucosal melanoma, a rare but deadly form of skin cancer.
Following the recent hype around immunotherapies in cancer, CEO Carole Renouf shares the greatest story never told… resistance… and what MIA is doing to address it.
A/Prof Wargo discusses the research she will be presenting as a keynote speaker at the upcoming Australasian Melanoma Conference.
Dr James Wilmott has been awarded the Wildfire award at this year's Cancer Institute NSW's Premier Awards for Outstanding Cancer Research.
The community has responded generously to our recent appeal to fund a specialised nursing position in an exciting new clinical trial.
We have developed a unique clinical trial that will use existing drugs to target rare genes in melanoma patients.
Data presented at the recent ASCO Annual Meeting showcased advances in melanoma research, particularly long-term survival data.
We value your privacy and want you to be familiar with how we collect, use and disclose your information.
Melanoma Institute Australia has partnered with IBM Research in Australia to help further advance melanoma identification using cognitive technology.
CEO Carole Renouf chats to senior clinicians and researchers as part of our "4 Questions With..." short video series.
MIA's 'Stop the Spread' campaign has been shortlisted in the 2016 Cannes Lions International Festival of Creativity.
MIA's doctors are converging on Chicago this week along with 40,000 delegates from around the globe at the biggest oncology conference in the world.
We are pleased to announce a recent expansion to the dermatology services at Melanoma Institute Australia.
This International Clinical Trials Day we reflect on the importance of clinical trials and the people who dedicate their lives to helping melanoma patients today and in the future.